2025 annual financial data
Beam Therapeutics 2025 Net margin
Direct answer
Net margin was -57.24%.
Operating income was -383,693,000 USD and net income was -79,992,000 USD.
Operating cash flow was -345,102,000 USD.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 139,743,000 USD
- Operating income
- -383,693,000 USD
- Net income
- -79,992,000 USD
- Operating cash flow
- -345,102,000 USD